Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mix

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2018
Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastomaIlinca Popp, Stefan Bott, Michael Mix, et al.
JCO Precision Oncology|January 20, 2022
Circulating Tumor DNA Allows Early Treatment Monitoring in BRAF- and NRAS-Mutant Malignant MelanomaJan Braune, Laura Keller, Florian Schiller, et al.
BMC Cancer|October 8, 2016
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)Oliver Oehlke, Michael Mix, Erika Graf, et al.
Plos One|April 11, 2020
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PETAlexis Platek, Michael Mix, Varun Chowdhry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2020
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in <sup>68</sup>GaPSMA-11 PET images of patients with primary prostate cancerConstantinos Zamboglou, Alisa S Bettermann, Christian Gratzke, et al.
IEEE Transactions on Medical Imaging|June 14, 2012
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapyTony Shepherd, Mika Teras, Reinhard R Beichel, et al.
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007Philipp Moritz Adrian Waibel, Ievgen Glavynskyi, Tobias Fechter, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2018
Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastomaIlinca Popp, Stefan Bott, Michael Mix, et al.
JCO Precision Oncology|January 20, 2022
Circulating Tumor DNA Allows Early Treatment Monitoring in BRAF- and NRAS-Mutant Malignant MelanomaJan Braune, Laura Keller, Florian Schiller, et al.
BMC Cancer|October 8, 2016
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)Oliver Oehlke, Michael Mix, Erika Graf, et al.
Plos One|April 11, 2020
Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PETAlexis Platek, Michael Mix, Varun Chowdhry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2020
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in <sup>68</sup>GaPSMA-11 PET images of patients with primary prostate cancerConstantinos Zamboglou, Alisa S Bettermann, Christian Gratzke, et al.
IEEE Transactions on Medical Imaging|June 14, 2012
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapyTony Shepherd, Mika Teras, Reinhard R Beichel, et al.
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007Philipp Moritz Adrian Waibel, Ievgen Glavynskyi, Tobias Fechter, et al.
Pageof 12